期刊文献+

奈达铂腹腔化疗后致不完全性肠梗阻二例 被引量:3

下载PDF
导出
摘要 例1:38岁,孕1产1。因发现下腹部包块进行性增大5月余于2011年5月5日收住我院。入院查体:体形消瘦。妇科检查:腹部可及一巨大包块,腹围97cm,上至剑突,下至耻骨联合,长41em。磁共振成像(MRI)示:腹盆腔占位,考虑恶性肿瘤:囊腺癌(附件来源可能性大)伴少量腹腔积液形成。
出处 《中国药物与临床》 CAS 2012年第10期1382-1384,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献8

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2Desoize B,Madoulet C. Particular aspects of platinum com- pounds used at present in cancer treatment. Crit Rev Oncol Hematol, 2002,42(3) : 317-325.
  • 3Heike-Takahashi M,Ohira T,et al. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice. Cancer Chemother Phamacol, 1995,35 (3) : 200-204.
  • 4Latorre A,Elena MD,Catino A,et al. Epithelial ovarian cancer:second and third line chemotherapy(review). Int J 0ncol,2002, 21(1) : 179-186.
  • 5Itch K,Yamashita T,Wakita H,et al. Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum containing chemothetapym of two cases. Jpn J Clin On- col, 1998,28(5) :343-346.
  • 6Poveda A. Gemcitabine in patients with ovarian cancer. CancerTreat Rev, 2005 (Suppl 4) : $29-$37.
  • 7胡士琴 徐晓俊 徐海燕.静脉注射奈达铂致过敏性休克1例.药物与临床,2006,4(8):61-61.
  • 8贾建忠,黄碧有,任洪波,蒋义.奈达铂腹腔内化疗联合拓扑替康治疗复发性卵巢癌[J].临床肿瘤学杂志,2004,9(6):646-647. 被引量:2

二级参考文献42

  • 1Sumi H,Ohtsu A,Boku N,et al.A case of inoperable esophageal carcinoma with hepatic and nodal metastases which showed a long-term survival after chemoradiotherapy including nedaplatin [J].JpnJ Clin Oncol,2000,30(9):406~409
  • 2Kaneko K,Ito H,Ito T,et al.A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy[J].Gan To Kagaku Ryoho,2001,28(6):831 ~834
  • 3Hirabayashi Y,Okada E.Combination chemotherapy with 254-S,ifosfamide and peplomycin for advanced or recurrent cervical cancer[J].Cancer,1992,71:2769 -2775
  • 4Adachi S,Ogasawara T,Yamasaki N,et al.A pilot study of nedaplatin and etoposide for recurrent gynecological malignancies [J].Oncol Rep,1998,5(4):881-884
  • 5Ito K,Adachi S,Itani Y,et al.A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies[J].JpnJ Clin Oncol,1999,29(6):299-302
  • 6Adachi S,Ogasawara T,Wakimoto E,et al.Phase Ⅰ/Ⅱ study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma[J].Cancer,2001,91 (1):74~ 79
  • 7Kodama J,Hashimoto I,Seki N,et al.Concurrent chemoradiotherapy for advanced cervical cancer-a pilot study [J].Gan To Kagaku Ryoho,2001,28(3):351-355
  • 8Adachi S,Ogasawara T,Tsubamoto H,et al.Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer[J].IntJ Clin Pharmacol Res,2001,21(3-4):105~110
  • 9Adachi S,Yamasaki N,Ogasawara T,et al.Combination chemotherapy using intravenous nedaplatin (254-S) and intraarterial cisplatin (CDDP) with transcatheter arterial embolization (TAE) for a patient with uterine cervical cancer: a case report[J].JpnJ Clin On
  • 10Kamiura S,Kobayashi K,Ohira H,et al.Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer-clinical investigation of adverse events [J].Gan To Kagaku Ryoho,2001,28(7):979-986

共引文献177

同被引文献12

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部